Pfizer to acquire Seagen for $43 billion
Pfizer will acquire Seagen, a firm specializing in the discovery and development of treatments for cancer, the firms announced on Monday. Read More
Exclusion of racial groups from cancer genomics research has negative impacts
The lack of genomic research for people with African ancestry is hampering efforts to reduce health disparities for people with cancer, according to recent research. Read More
Correlation of enzyme to survival reveals potential target for metastatic solid tumors
The enzyme lysyl hydroxylase 1 (LH1) promotes the migration and metastasis of solid tumor cells and is associated with shorter survival, according to a recent study published in Molecular Cancer. Read More
Long COVID less likely after Omicron than after original virus, Swiss researchers find
Swiss researchers have found that the Omicron variant of SARS-CoV-2 is much less likely to lead to long COVID than the original wild-type virus circulating at the start of the COVID-19 pandemic. Read More
Convert a smartphone into a fluorescent microscope for under $50
A few simple components can convert a smartphone or tablet into a fluorescent microscope for under $50 per unit. Read More
Nasal antibody modulates inflammatory response in COVID-19 patients in small clinical trial
A nasally administered monoclonal antibody modulated inflammatory responses in COVID-19 patients in a small clinical trial. Read More
Protein expression biomarker may identify likely responders to potential breast cancer drug
Targeting women who express certain proteins could increase the response rate to a breast cancer drug that achieved mixed results in previous clinical trials, according to a paper published in EMBO Molecular Medicine. Read More
Modifying messenger RNA provides new Alzheimer’s disease target
Researchers in China have found that reducing the methylation of a key messenger RNA can promote the migration of macrophages into the brain and ameliorate symptoms of Alzheimer’s disease in mice. Read More
Light-controlled drug delivery platform opens opportunities to treat pain, cancer
A self-powered, light-controlled drug delivery platform could enable the controlled release of medicines and eliminate the need to surgically extract the implant after use, according to research published in the Proceedings of the National Academy of Sciences (PNAS). Read More
Study supports genetic testing for people with cerebral palsy
A meta-analysis of recent research on the genetics of cerebral palsy provides evidence that genetic testing should be offered as the standard of care for people with the disorder. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
